CD
GNMX

Carl Domino’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Carl Domino’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$55K Hold
43,273
– – 0.07% 113
2017
Q2 		$58K Buy
43,273
+10,000
+30% +$14.5K 0.07% 118
2017
Q1 		$62K Hold
33,273
– – 0.07% 120
2016
Q4 		$172K Hold
33,273
– – 0.18% 105
2016
Q3 		$179K Hold
33,273
– – 0.17% 114
2016
Q2 		$185K Sell
33,273
-861
-3% -$4.52K 0.17% 116
2016
Q1 		$150K Hold
34,134
– – 0.14% 128
2015
Q4 		$205K Hold
34,134
– – 0.16% 122
2015
Q3 		$267K Hold
34,134
– – 0.21% 97
2015
Q2 		$209K Hold
34,134
– – 0.14% 132
2015
Q1 		$275K Sell
34,134
-3,000
-8% -$22.6K 0.21% 111
2014
Q4 		$188K Buy
37,134
+17,000
+84% +$84K 0.1% 158
2014
Q3 		$104K Hold
20,134
– – 0.06% 168
2014
Q2 		$156K Hold
20,134
– – 0.08% 166
2014
Q1 		$141K Sell
20,134
-1,148
-5% -$8.96K 0.07% 164
2013
Q4 		$127K Sell
21,282
-2,846
-12% -$18.6K 0.07% 165
2013
Q3 		$188K Sell
24,128
-5,850
-20% -$27.2K 0.11% 149
2013
Q2 		$114K Buy
+29,978
New +$123K 0.06% 154

Other funds holding GNMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCMW
Northern Capital Management (Wisconsin) Madison, Wisconsin $373M AUM 11.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Carl Domino's GNMX Position: Q3 2017 in Review

Carl Domino held its Aevi Genomic Medicine Inc (GNMX) position steady in Q3 2017 at 43,273 shares worth $55K. The position accounts for 0.07% of the portfolio, ranked #113.

Carl Domino first reported a position in GNMX in Q2 2013 and has held it in 18 quarters since. The position peaked at $275K in Q1 2015. 49 funds tracked by Wall St. Rank hold GNMX as of Q3 2017.

  • Carl Domino held 43,273 shares of Aevi Genomic Medicine Inc worth $55K as of Q3 2017.
  • Carl Domino left its Aevi Genomic Medicine Inc share count unchanged in Q3 2017.
  • Aevi Genomic Medicine Inc made up 0.07% of Carl Domino's portfolio in Q3 2017, its #113 holding.
  • Carl Domino first reported a position in Aevi Genomic Medicine Inc in Q2 2013 and has held it in 18 quarters since.
  • Carl Domino's Aevi Genomic Medicine Inc position peaked at $275K in Q1 2015.
  • 49 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.